Ovarian Cancer Trial, Recruiting NCT05833321 Sponsor: Centre Hospitalier Metropole Savoie Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT05833321
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old
  • People who have been diagnosed with a cancer originating in the ovaries and whose doctor has recommended chemotherapy as part of their treatment
  • People who have been diagnosed with endometrial cancer (cancer of the lining of the uterus) and whose doctor has recommended chemotherapy as part of their treatment
  • People who have not been diagnosed with any other type of cancer in the past five years
  • People who have given their consent to participate in the trial
  • People who are enrolled in a French Social Security scheme

Who may not be able to join:

  • People diagnosed with a cancer of ovarian origin that does not require chemotherapy treatment
  • People diagnosed with endometrial cancer that does not require chemotherapy treatment
  • People found to have an additional, unrelated cancer at the time of the trial, unless it is a skin cancer or cervical cancer (confirm with trial site)
  • People who have a pacemaker (a small device implanted in the chest to help regulate heartbeat)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: fillon aurélie, Centre Hospitalier Metropole Savoie

Phone: 0479965813

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Metropole Savoie
Registry
ClinicalTrials.gov
Start date
20 November 2022
Est. completion
1 October 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

clinical screening for sarcopenia; Proposal of a composite score for the detection of sarcopenia usable in clinical routine

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov